Hot flashes: Is a hot flash just a hot flash?

Menopause

Volumn 21, Issue 6, 2014, Pages 551-552

  Nachtigall, Lila ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAZEDOXIFENE; BRAIN RECEPTOR; CONJUGATED ESTROGEN; ESTROGEN; GABAPENTIN; PAROXETINE; PLACEBO; 4 AMINOBUTYRIC ACID; AMINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DELAYED RELEASE FORMULATION;

CARDIOVASCULAR RISK; EDITORIAL; ESTROGEN THERAPY; FEMALE; HEALTH STATUS; HORMONAL THERAPY; HOT FLUSH; HUMAN; NIGHT SWEAT; NORADRENALIN BRAIN LEVEL; POSTMENOPAUSE; SLEEP; SLEEP DISORDER; DELAYED RELEASE FORMULATION; HOT FLASHES;

AMINES; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; DELAYED-ACTION PREPARATIONS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS;

EID: 84901645052     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000250     Document Type: Editorial

References (10)

1. Kronenberg F. Hot flashes: epidemiology and physiology. Ann N Y Acad Sci 1990;592:52-86, discussion 123-133.
2. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008;23: 1507-1513.
3. Freedman RR. Physiology of hot flashes. Am J Hum Biol 2001;13:453-464.
4. Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause 2013;20:518-524.
5. Thurston RC, El Khoudary SR, Sutton-Tyrrell K, et al. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause 2011;18:1044-1051.
6. Roussauw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
7. Greene RA. Cerebral blood flow. Fertil Steril 2000;73:143.
8. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol 2014;123:202-216.
9. Simon JA, Portman DJ, Kaunitz AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause 2013;20:1027-1035.
10. Pinkerton J, Kagan R, Portman D, et al. Phase 3 randomized, controlled study of gastroretentive gabapentin for treatment of moderate to severe hot flashes in menopause. Menopause 2014;21:XXX-XXX.